Home example 2 - Pharmamarketeer

onderzoek

Ofatumumab Bests Teriflunomide in Head-to-Head MS Trials

Findings from the phase 3 ASCLEPIOS I and II studies showed that treatment with ofatumumab (Novartis), a CD20-directed cytolytic monoclonal antibody, resulted in a highly significant and clinically meaningful reduction...

Monthly Prescribing Reference (MPR): Drugs in the Pipeline

6 x gelezen

onderzoek

Researchers develop new tool that acts like colonoscopy

Colonoscopy Your gut bacteria could say a lot about you, such as why you’re diabetic or how you respond to certain drugs.But scientists can see only so much of the gastrointestinal tract to study the role of gut...

News-Medical.Net

6 x gelezen

technologie

Health minister invites Japanese pharma cos to collaborate with Indian firms for research and innovation

Health minister invites Japanese pharma cos to collaborate with Indian firms for research and innovation Union minister of health and family welfare, Dr Mansukh Mandaviya has invited Japanese companies to collaborate...

Pharma Biz

6 x gelezen

wet- en regelgeving

Lilly gets EMA nod for Verzenio in breast cancer

Verzenio (abemaciclib) has been cleared by the EMA to treat women with hormone receptor-positive (HR+), epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer, as a first-line...

PMLiVE

6 x gelezen

farma-industrie

Pfizer manufacturing ills mean ongoing shortages for hospitals

Pfizer acknowledged Tuesday that it continues to struggle with manufacturing at some Hospira plants, an issue that bodes ill not just for investors but also for U.S. hospitals. The manufacturing problems at Hospira that...

FiercePharma

6 x gelezen

marketing

Maak je content ‘merkwaardig’ met archetypen

Humor is een beproefde manier om aandacht te krijgen. Dus ja, er zijn zeker redenen om als merk humor in te zetten op social media. Maar naar mijn mening gebeurt het te vaak, te gemakkelijk en vooral ook om de verkeerde...

Frankwatching.nl

6 x gelezen

wet- en regelgeving

Sandoz bags EC marketing approval for biosimilar Ziextenzo

Sandoz, a Novartis division and the pioneer and global leader in biosimilars, has announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo (pegfilgrastim).

Pharma Biz

6 x gelezen

farma-industrie

J&J unit to pay $360 million to U.S. to resolve charity kickback probe

A unit of Johnson & Johnson has agreed to pay the U.S. government $360 million to resolve an investigation into its financial support of charities that help Medicare patients cover out-of-pocket drug costs, the U.S...

Reuters Health

6 x gelezen

marketing

Digitale adoptie gaat nu razendsnel, zo blijf je aangehaakt

De verschuiving van werken, winkelen en leven naar online in deze coronaperiode heeft als gevolg dat adoptieprocessen van digitale middelen in een stroomversnelling terecht zijn gekomen. Maar wat voor...

Marketingfacts.nl

5 x gelezen

onderzoek

International study uncovers three molecules with potential for treating epilepsy

Treating epilepsy
A major international study has uncovered three molecules that have the potential to be developed into new drugs to treat epilepsy.

News-Medical.Net

5 x gelezen

Latest articles

Ofatumumab Bests Teriflunomide in Head-to-Head MS Trials

Researchers develop new tool that acts like colonoscopy

Health minister invites Japanese pharma cos to collaborate with Indian firms for research and innovation

Lilly gets EMA nod for Verzenio in breast cancer

Pfizer manufacturing ills mean ongoing shortages for hospitals

Maak je content ‘merkwaardig’ met archetypen

Sandoz bags EC marketing approval for biosimilar Ziextenzo

J&J unit to pay $360 million to U.S. to resolve charity kickback probe

Digitale adoptie gaat nu razendsnel, zo blijf je aangehaakt

International study uncovers three molecules with potential for treating epilepsy

Wekelijkse highlights per e-mail

Algemene informatie